Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide pens deliver a fixed amount of medication that gradually depletes with each weekly injection. Most patients complete one pen within 28 days, but the exact timeline depends on your personalized dose progression and how your body responds to treatment. PlexusDx provides compounded semaglutide injections that work on your schedule, not a fixed commercial timeline.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

Standard Semaglutide Pen Duration and Supply

A single semaglutide pen contains 3 milliliters of medication formulated at 2.4 milligrams per milliliter, delivering a total of 7.2 milligrams per pen. When taking the standard once-weekly injection, one pen covers exactly four weeks of treatment before needing replacement. This 28-day supply aligns with most refill schedules and pharmacy delivery cycles, making planning straightforward for patients starting their weight loss journey.

The duration remains consistent as long as you maintain the same weekly dose without adjustment. However, if your healthcare provider modifies your dose upward during dose titration—a common practice during the first eight to twelve weeks—your pen supply may deplete faster. Conversely, if you remain on a lower starting dose longer, one pen might last slightly beyond four weeks, though waste becomes a consideration since pens cannot be stored indefinitely after initial use.

Factors That Affect How Long Your Medication Lasts

Your starting dose significantly impacts how quickly your pen depletes. Patients beginning at 0.25 milligrams per week consume medication more slowly than those escalating to 0.5 milligrams or higher within the first month. Your dose progression schedule—whether your doctor increases your injection strength weekly, biweekly, or monthly—determines if you'll stretch one pen beyond four weeks or need a new one sooner.

Body weight, metabolic response, and individual medication absorption also play roles in determining your treatment timeline. Patients with higher starting weights or greater insulin resistance may benefit from faster dose escalation, accelerating pen depletion. Additionally, proper injection technique ensures you're not wasting medication during administration, so learning correct needle angle and injection depth from your prescriber or pharmacist helps maximize each pen's usable supply.

PlexusDx Compounded Semaglutide: Flexible Dosing Without Fixed Timelines

PlexusDx compounded semaglutide injections eliminate rigid pen supply constraints by allowing fully customized dosing tailored to your progression schedule. Rather than being locked into commercial pen configurations, your provider can prescribe exact dose amounts that match your body's response and your timeline. This flexibility means you pay one flat monthly price at $189/mo month-to-month, or from $149/mo on the 6-month plan, regardless of whether your dose increases or remains stable—your cost stays the same while your clinical needs evolve.

Licensed 503A compounding pharmacies prepare PlexusDx semaglutide in quantities matching your prescribed weekly injection schedule, so you receive exactly what you need without overpaying for unused medication. If your doctor adjusts your dose upward during week three, your next shipment reflects that change seamlessly. This personalized approach to medication management removes the guesswork around pen depletion and ensures continuous access across all 50 states without insurance requirements or membership fees.

Maximizing Your Medication Supply and Planning Refills

Planning ahead for medication refills prevents gaps in your treatment that can interrupt weight loss momentum. Mark your calendar for day 21 of your first pen's use to request a refill, ensuring your new supply arrives before depletion. Store opened pens in the refrigerator at 36 to 46 degrees Fahrenheit, and keep unopened pens at room temperature away from direct sunlight; proper storage extends usability and prevents medication degradation that shortens effective supply.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Genetic Factors Influencing Your Personalized Dosing Timeline

Your genetic makeup influences how quickly you respond to semaglutide and how rapidly your doctor should escalate your dose, indirectly affecting how long your medication supply lasts. Specific genetic variants in your GLP-1 receptor pathway—like GLP1R rs6923761—affect medication sensitivity and optimal dosing speed. PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis that maps 14 biological pathways and 49 peptides to reveal your unique response profile, helping your provider design a dosing schedule matched to your genetic predispositions.

Understanding variants in GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 provides insights into your metabolic efficiency and appetite regulation baseline, informing whether faster or slower dose escalation serves you best. The $298 test after your first month of treatment reveals 150+ genetic insights that optimize your medication timeline and improve outcomes. Patients with data-driven dosing strategies often achieve weight loss targets with better medication timing, potentially altering how long each supply cycle needs to sustain their progress.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How many weeks does a standard semaglutide pen last?

A standard semaglutide pen contains 3 milliliters and lasts exactly four weeks at a consistent weekly dose, delivering one injection per week. If your provider increases your dose during titration, your pen may deplete faster. PlexusDx compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan provides flexible supply matching your exact dose progression without wasted medication.

What happens if I need to increase my dose before my pen runs out?

Increasing your dose mid-pen means you'll inject larger amounts each week, depleting your current supply faster than expected. With PlexusDx compounded semaglutide, dose adjustments flow seamlessly into your next monthly shipment at the same flat price—your dose may increase, but your monthly cost of $189 (starting price) stays locked. This removes the penalty of dose escalation that commercial pens sometimes create.

Can I store a semaglutide pen longer than four weeks?

Once opened, semaglutide pens remain stable for 28 days refrigerated at 36 to 46 degrees Fahrenheit, matching the standard four-week supply duration. Unopened pens last up to 36 months at room temperature, but opened pens must not exceed 28 days of storage before degradation compromises potency. PlexusDx delivers fresh compounded doses aligned with your schedule, ensuring you never store medication unnecessarily.

Does a higher dose deplete my pen faster?

Yes, higher weekly doses deplete your pen supply in fewer weeks because you're injecting larger volumes each time. A patient escalating from 0.25 milligrams to 1.0 milligram weekly uses medication four times faster than someone staying at the starting dose. PlexusDx pricing remains flat regardless of your dose level, so escalating your medication never increases your monthly cost—protecting your budget while optimizing your clinical progression.

How does the Precision Peptide Genetic Test affect my dosing timeline?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves